GILD Gilead Sciences, Inc. | US3755581036
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 32.282.725.630 | 30.421.829.010 | 6.12% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 9,63 | -0,77 | 1353.91% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 25 | 26 | 3.85% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |